Well-differentiated versus less-differentiated endometrial carcinoma

Area of Science:

• Gynecologic Oncology
• Pathology
• Clinical Medicine

Background:

• Endometrial carcinoma grading (well-differentiated vs. less-differentiated) is crucial for prognosis.
• Understanding clinical differences between tumor grades aids in treatment planning.

Purpose of the Study:

• To compare clinical risk factors, symptoms, and operative findings between well-differentiated (grade 1) and less-differentiated (grades 2-3) endometrial carcinoma.
• To investigate potential differences in disease presentation and patient characteristics based on tumor grade.

Main Methods:

• Retrospective review of 71 surgically staged endometrial carcinoma cases.
• Cases divided into Grade 1 (Group I, n=40) and Grades 2-3 (Group II, n=31) based on tumor differentiation.
• Comparison of patient demographics, medical history, presenting symptoms, and operative findings between groups.

Main Results:

• No significant differences observed in patient age, gravidity, parity, comorbidities (hypertension, diabetes), menopausal duration, hormonal replacement therapy use, or histological type.
• Presenting symptoms and duration of uterine bleeding before diagnosis were similar between groups.
• Well-differentiated tumors (Grade 1) were associated with significantly higher rates of obesity (p<0.02), smaller uterine size (p<0.01), and less advanced disease stage (p<0.0005).

Conclusions:

• Obesity, smaller uterus, and less advanced stage are associated with well-differentiated endometrial carcinoma.
• Similar patient age and bleeding duration suggest less-differentiated tumors may be intrinsically more aggressive rather than progressing from well-differentiated types.
• Further research is needed to validate the hypothesis of inherent tumor aggressiveness in less-differentiated endometrial carcinoma.